Raaj Medisafe India Limited reported a significant turnaround in profitability for the first quarter of FY27, with net profit rising 35% year-on-year to ₹197.37 lakh. The Ujjain-based manufacturer of plastic products and hygiene items saw its revenue from operations surge 86% to ₹2,945.91 lakh against ₹1,582.70 lakh in Q1FY26. This performance contrasts sharply with the preceding quarter (Q4FY26), where the company posted a net loss of ₹322.63 lakh.

The Board of Directors approved the unaudited financial results in its meeting held on August 12, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by statutory auditors GDK & Associates, who issued their report on the same date.

Financial Performance Overview

Revenue growth was broad-based across the company’s two reportable segments: Plastics and Hygiene. The Plastics Division, which manufactures bottles, caps, and liners, generated segment revenue of ₹2,112.00 lakh, up from ₹1,162.56 lakh in Q1FY25. The Hygiene Division, dealing in sanitary napkins and diapers, reported segment revenue of ₹851.17 lakh, doubling from ₹422.90 lakh in the prior year.

Expenses rose in tandem with revenue, increasing 87.7% to ₹2,697.23 lakh. Cost of materials consumed stood at ₹2,129.76 lakh, while employee benefits expense increased to ₹165.22 lakh from ₹113.25 lakh. Finance costs were contained at ₹86.36 lakh, down from ₹107.97 lakh in the previous quarter but higher than ₹68.13 lakh in Q1FY26.

Segmental Insights

The Plastics Division remained the primary profit driver, contributing ₹350.74 lakh to segment results, a sharp recovery from ₹105.96 lakh in Q4FY26 and an improvement over ₹178.18 lakh in Q1FY25. The Hygiene Division reported a segment result of ₹31.08 lakh, down significantly from ₹172.22 lakh in the previous quarter but up from ₹77.47 lakh in Q1FY25.

Total assets increased to ₹12,592.40 lakh as on June 30, 2026, from ₹12,134.87 lakh at the end of FY26. The Plastics Division accounted for ₹7,174.99 lakh of total assets, while the Hygiene Division held ₹5,385.41 lakh.

What the Numbers Show

A notable divergence exists between top-line growth and bottom-line expansion. While revenue surged 86% year-on-year, net profit grew only 35%. This indicates that operating margins contracted during the quarter. Specifically, cost of materials consumed grew disproportionately faster than revenue, suggesting pressure on gross margins or a shift in product mix towards lower-margin items. Additionally, other income jumped to ₹15.45 lakh from negligible levels in the prior year, contributing to the pre-tax profit but not offsetting the margin compression from core operations.

The Board of Directors of Raaj Medisafe India Ltd approved the unaudited financial results for the quarter ended June 30, 2026, during a meeting held on August 12, 2026. In a significant leadership change, the Board appointed Mr. Vipul Parakh as Chief Financial Officer (CFO), effective August 12, 2026, following the resignation of Ms. Fatema Dadani Patel. Shareholders must note that the Register of Members will close from September 15, 2026, to September 21, 2026, to determine eligibility for the upcoming Annual General Meeting (AGM).

Mr. Parakh is a Chartered Accountant with over 28 years of professional experience across the service and manufacturing sectors. His appointment brings expertise in end-to-end financial operations, including financial reporting, budgeting, compliance, and SAP implementation. He has led financial functions in both non-profit and for-profit organizations, with a focus on strategic financial planning and statutory compliance.

Key Appointments and Resignations

The meeting addressed key leadership changes within the company:

AGM and Shareholder Logistics

The Board fixed Monday, September 21, 2026, at 3.00 PM as the date for the 41st Annual General Meeting, to be held via Video Conferencing or Other Audio-Visual Means (VC/OAVM). The cutoff date for determining eligibility to participate in E-voting is September 14, 2026. M/s. M.Maheshwari & Associates has been appointed as the Scrutinizers for the E-voting process.

Compliance and Reporting

The Board took on record the Limited Review Report of the Statutory Auditor regarding the Q1FY26 results. Additionally, the Board noted the Secretarial Audit Report for the year ended March 31, 2026, issued by M/s. M.Maheshwari & Associates, Practicing Company Secretaries. The Directors’ Report and Corporate Governance Report for FY26 were also approved, with authorization granted to designated persons to sign these documents.

The Board adopted the Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026. It also took on record several reports submitted to the Bombay Stock Exchange (BSE) in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR). These include:

• Statement of Investors’ complaints (included in the Integrated Corporate Governance Report)
• Shareholding Pattern
• Integrated Corporate Governance Report
• Statement of variation of utilization of funds raised on March 26, 2026, through Preferential Allotment of Equity Shares
• Secretarial Compliance Report for the year ended March 31, 2026

Transactions entered into with related parties during the quarter ended June 30, 2026, were also considered and taken on record by the Board.